Senior Scientist, Child Health Evaluative Sciences, Hospital for Sick Children
Professor, Institute of Health Policy, Management and Evaluation, University of Toronto
Dr. Wendy Ungar is a Senior Scientist in Child Health Evaluative Sciences at the Hospital for Sick Children Research Institute, Professor in the Institute of Health Policy, Management and Evaluation, and Adjunct Scientist at the Institute for Clinical Evaluative Sciences. Dr. Ungar has a Master’s degree in Pharmacology and Therapeutics from McGill University and a PhD in Health Policy, Management and Evaluation, from the University of Toronto. Dr. Ungar leads a program of research in the application of health economic methods to the pediatric population with a current focus on genomics and developmental disorders. In 2007, Dr. Ungar started Technology Assessment at SickKids (TASK), a research unit focusing on technology assessment in child health.
Sydney G. Frankfort Chair in Family Medicine
Professor, Family and Community Medicine, University of Toronto
Dr. June Carroll holds the Sydney G. Frankfort Chair in Family Medicine and is a Professor and Clinician Scientist in the Department of Family and Community Medicine at the University of Toronto. She practises family medicine at Mount Sinai Hospital in Toronto. Dr. Carroll’s academic focus is the development, evaluation, and implementation of practice tools and knowledge translation strategies to enable primary care providers and their patients to make appropriate use of genomic medicine. She is the Co-founding Director of Genetics Education Canada–Knowledge Organization (GEC-KO), the mandate of which is to enhance the genomics literacy of health care providers across Canada through the development, collection, dissemination, and evaluation of educational materials on genomics.
Scientist, Li Ka Shing Knowledge Institute, St. Michael’s Hospital
Assistant Professor, Institute of Health Policy, Management and Evaluation, University of Toronto
Dr. Bombard is a genomics health services researcher and Scientist at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital. She is an Assistant Professor at the University of Toronto in the Institute of Health Policy Management and Evaluation. Her research focuses on evaluating the adoption of new genomic technologies in clinical practice. She also conducts public and patient engagement research to advance health technology assessment and health service delivery. Dr. Bombard is active in numerous international policy advisory committees, and her research informs policy development in this area. In 2014, Dr. Bombard was the inaugural recipient of the Maurice McGregor Award for Demonstrated Excellence and Leadership Potential from the Canadian Agency for Drugs and Technologies in Health (CADTH), and in 2011, she received a “Rising Star” award from the Canadian Institutes of Health Research (CIHR) Institute of Health Services and Policy Research. Recently, she was awarded a CIHR Foundation grant as an Early Career Investigator, and she also holds a CIHR New Investigator Award.
Chair, Ethics Committee, TRIO Fertility and the Reproductive Care Centre
Shawn Winsor is a bioethicist working in public policy and a Vanier Canada Graduate Scholar in the Health Policy PhD program at the Centre for Health Economics and Policy Analysis at McMaster University. Mr. Winsor has been the Director of ethics programs at Sunnybrook Health Sciences Centre and Trillium Health Partners. He co-founded the ethics programs at TRIO Fertility and the Reproductive Care Centre (Mississauga–Oakville), where he continues to chair their ethics committee. Mr. Winsor has served on OHTAC’s Decision Determinants Subcommittee, has acted as an expert reviewer for CADTH, and is currently advising the Canadian Task Force on Preventive Health Care on the development of its guideline for fetal aneuploidy screening.
Medical Director, BORN Ontario
Principal Investigator, Canadian Inherited Metabolic Disease Research Network
Dr. Chakraborty is a physician certified in medical biochemistry and pediatrics, with a subspecialty in biochemical genetics. He joined the Children’s Hospital of Eastern Ontario (CHEO) in 2003 as a clinician seeing patients with inborn errors of metabolism. In 2006, he led the transition of Ontario's newborn screening program to Ottawa, leading to the establishment of Newborn Screening Ontario at CHEO. In 2008, he was instrumental in the founding of the Better Outcomes Registry and Network (BORN Ontario) as a prescribed registry in Ontario. Dr. Chakraborty is currently the Medical Director at BORN Ontario and a principal investigator for the Canadian Inherited Metabolic Disease Research Network.
Medical Geneticist, Trillium Health Partners
Dr. Goh is a Medical Geneticist at Trillium Health Partners, with a general genetics practice, including Pediatric and Cancer Genetics, with a special focus in cardiac and prenatal genetics. In addition to her clinical perspective, she has completed a Master’s degree in Health Services Research, with an emphasis on Health Policy. Dr. Goh was part of the analysis team for the Provincial Wait Times project led by the Ontario Genetics Secretariat and is currently a Clinical Representative on the Education, Ethics, and Public Policy Committee for the Canadian College of Medical Geneticists.
Professor, Department of Epidemiology and Community Medicine, University of Ottawa
Dr. Wilson is trained in internal medicine and public health medicine. She joined the Department of Epidemiology and Community Medicine at the University of Ottawa in 2002 and has served as Director of Graduate Studies and Director of the Public Health and Preventive Medicine Residency Program. She is also a member of the Canadian Task Force for Preventive Health Care. In her research, Dr. Wilson applies a public health lens to emerging health technologies, particularly genomics, and her interdisciplinary research program spans diverse questions relating to the evidence for genome-based tests and health interventions, different service delivery models, and the personal, family, and social implications of genomics.
Geneticist, University Health Network, University of Toronto
Dr. Kim is a medical geneticist with the University Health Network, Mount Sinai, and the Hospital for Sick Children. He received his MD and PhD from the University of Toronto and completed a residency in internal medicine. Dr. Kim continued his fellowship in medical genetics at the Hospital for Sick Children using genomic sequencing in rare diseases. He is interested in complex care for patients with hereditary disorders, transition of pediatric patients, and incorporating novel genetic technologies into clinical care.
Chief, Clinical Laboratory Genetics, and Director of Genome Diagnostics, University Health Network
Professor, Laboratory Medicine and Pathobiology, University of Toronto
Dr. Kamel-Reid is a professor of Laboratory Medicine and Pathobiology at the University of Toronto and the Chief of Clinical Laboratory Genetics and Director of Genome Diagnostics at the University Health Network. Dr. Kamel-Reid’s clinical service laboratory focuses on the diagnosis, prognosis, and monitoring of many hematological malignancies, as well as mutation testing in solid tumours. She is a member of the Cancer Care Ontario Molecular Oncology Advisory Committee, the Ontario Personalized Medicine Network, the Ontario Ministry of Health Genetics Testing Advisory Committee, and the Ontario Genetics Secretariat Executive. Her research program is currently focused on further developing the concept of precision medicine and its utility in the clinical setting by assessing the use of new technologies to develop more comprehensive genetic tests for clinical use.
Assistant Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto
Dr. Lerner Ellis is an Assistant Professor in the University of Toronto’s Department of Laboratory Medicine and Pathobiology, a Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and an Associate at the Ontario Institute for Cancer Research. Dr. Lerner-Ellis completed his PhD in human genetics at McGill University and completed training in Clinical Molecular Genetics at Harvard Medical School. He currently serves as Head of Advanced Molecular Diagnostics at Toronto’s Mount Sinai Hospital. Dr. Lerner-Ellis’s core research interests are in molecular diagnostics as applied to breast and colon cancer, with the aim of evaluating the extent to which genomic information can be used in the diagnosis, treatment, and prevention of disease. He is focused on improving genetic testing through greater reliance on new sequencing technologies.
Patient and Public Representative
Mr. Feldman is a retired single parent of a 15-year-old child with complex medical issues, without a certain genetic diagnosis. Mr. Feldman currently focuses his time on fully caring for his daughter and participating in volunteer activities at the Bloorview Research Institute, where he has acted as Chair of the Family Engagement Committee.
Ms. Quinlan is a parent of a young child with special needs and an educator at Holland Bloorview Kids Rehabilitation Hospital, managing education programs for children with disabilities and advancing family-centred care. She recently organized the Patients and Providers Advancing Care Experiences (PACE) forum, a dynamic day-long forum that brought together health care organizations and families from southwestern Ontario interested in strengthening patient engagement in health care decision making.
Patients, families and the public are central to improving health quality.
Are you passionate about quality health care for all Ontarians? Stay in-the-know about our newest programs, reports and news.